Prostate cancer is curable when detected early, yet an American man dies from the disease every 18 minutes. Affecting one in seven men, this disease is even more common than breast cancer (which affects one in eight women), but public awareness and research funding to improve diagnosis and treatment are still lacking.
That’s where AdMeTech Foundation – which works with some of the greatest minds in medicine, including doctors at Brigham and Women’s (BWH) and Massachusetts General Hospitals (MGH) and the Dana Farber Cancer Center (DFCC) – plays an important role. My co-founders and I established AdMeTech in 1997 to help expedite the development of better diagnostic tools to detect and treat aggressive prostate cancer earlier. Accurate diagnosis is the biggest challenge today in prostate cancer care, so one of our main efforts has been The Manogram® Project. This research, education, awareness and advocacy initiative was designed to be men’s answer to women’s regular mammograms.
As a Boston-based foundation, we’ve benefited tremendously from long-standing collaborations.